Evidence map›Paper›PMID 21205742›Full record

ArticleCancer prevention research (Philadelphia, Pa.)2011

Resveratrol-induced apoptosis is mediated by early growth response-1, Krüppel-like factor 4, and activating transcription factor 3.

Nichelle C Whitlock, Jae Hoon Bahn, Seong-Ho Lee, Thomas E Eling, Seung Joon Baek

Open access · bronzeAbstract read
In one paragraph

Article in Cancer prevention research (Philadelphia, Pa.), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 54 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Role ofInternational journal of molecular sciences · 2018
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Nichelle C WhitlockLaboratory of Environmental Carcinogenesis, Department of Pathobiology, College of Veterinary Medicine, University of Tennessee, Knoxville, Tennesse 37996, USA.
Jae Hoon Bahn
Seong-Ho Lee
Thomas E Eling
Seung Joon Baek
National Institute of Environmental Health Sciences · USUniversity of Tennessee at Knoxville · US

Funding

Anti-carcinogenic Activity Of Cox inhibitors and NAG-1ZIAES010016 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI ELING, THOMAS · 2009 to 2013
$8.3M
PPAR-gamma ligands in colorectal cancerR01CA108975 · NCI · UNIVERSITY OF TENNESSEE KNOXVILLE · PI BAEK, SEUNG JOON · 2006 to 2010
$1.0M
NCI NIH HHS R01 CA108975NCI NIH HHS R01CA108975
6 · The paper itself

Abstract

Resveratrol, a dietary phytoalexin readily available in the diet, is reported to possess antitumorigenic properties in several cancers, including colorectal. However, the underlying mechanism(s) involved is not completely understood. In the present study, we investigated the effect of resveratrol treatment on gene modulation in human colorectal cancer cells and identified activating transcription factor 3 (ATF3) as the most highly induced gene after treatment. We confirmed that resveratrol upregulates ATF3 expression, both at the mRNA and protein level, and showed resveratrol involvement in ATF3 transcriptional regulation. Analysis of the ATF3 promoter revealed the importance of early growth response-1 (Egr-1; located at -245 to -236) and Krüppel-like factor 4 (KLF4; located at -178 to -174) putative binding sites in resveratrol-mediated ATF3 transactivation. Specificity of these sites to the Egr-1 and KLF4 protein was confirmed by electrophoretic mobility shift and chromatin immunoprecipitation assays. Resveratrol increased Egr-1 and KLF4 expression, which preceded ATF3 expression, and further suggests Egr-1 and KLF4 involvement in resveratrol-mediated activity. We provide evidence for Egr-1 and KLF4 interaction in the presence of resveratrol, which may facilitate ATF3 transcriptional regulation by this compound. Furthermore, we demonstrate that induction of apoptosis by resveratrol is mediated, in part, by increased ATF3 expression. Taken together, these results provide a novel mechanism by which resveratrol induces ATF3 expression and represent an additional explanation of how resveratrol exerts its antitumorigenic effects in human colorectal cancer cells.

Indexed as

Activating Transcription Factor 3Anticarcinogenic AgentsApoptosisBase SequenceBinding SitesBlotting, WesternCell Line, TumorCell ProliferationChromatin ImmunoprecipitationColorectal NeoplasmsEarly Growth Response Protein 1Electrophoretic Mobility Shift AssayHumansImmunoenzyme TechniquesImmunoprecipitationKruppel-Like Factor 4Activating Transcription Factor 3Anticarcinogenic AgentsATF3 protein, humanEarly Growth Response Protein 1EGR1 protein, humanKLF4 protein, humanKruppel-Like Factor 4Kruppel-Like Transcription FactorsLuciferasesResveratrolRNA, MessengerStilbenes

Identifiers

PMID21205742
PMCPMC3064282
OpenAlexW2105237310

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.